300 results about "Acridine derivatives" patented technology

Fluorescent biosensor molecules, fluorescent biosensors and systems, as well as methods of making and using these biosensor molecules and systems are described. These biosensor molecules address the problem of obtaining fluorescence emission at wavelengths greater than about 500 nm. Biosensor molecules generally include an (1) an acridine-based fluorophore, (2) a linker moiety and (3) a boronate substrate recognition / binding moiety, which binds polyhydroxylate analytes, such as glucose. These biosensor molecules further include a “switch” element that is drawn from the electronic interactions among these submolecular components. This fluorescent switch is generally “off” in the absence of bound polyhydroxylate analyte and is generally “on” in the presence of bound polyhydroxylate analyte. Thus, the reversible binding of a polyhydroxylate analyte essentially turns the fluorescent switch “on” and “off”. This property of the biosensor molecules, as well as their ability to emit fluorescent light at greater than about 500 nm, renders these biosensor molecules particularly well-suited for detecting and measuring in-vivo glucose concentrations.

The invention relates to the field of analyzing immunological determination, in particular to a method for immunological detection by combining an acridinium ester labeling technology with general magnetic particles and an immunological determination (quantitative / qualitative) kit which is prepared by utilizing the method. According to the method disclosed by the invention, substances, such as acridinium ester or acridine sulfonamide are used for labeling and detecting an antigen or an antibody, biotin is used for labeling and capturing the antigen or the antibody, and the immunological determination of biomolecules is carried out by combining the general (chain enzyme) avidin labeled magnetic particles. The method disclosed by the invention has the advantages of high sensitivity, wide detection range and capabilities of realizing the automation easily and having a wide application prospect in the field of the immunological detection.

The invention relates to a thermal activation delayed fluorescent material with a general formula of the structure shown as the formula (I) or the formula (II). D is one of phenoxazinyl, phenothizainyl, 9,9-dimethyl acridine, 9-methyl phenazinyl, 9-phenyl phenazinyl, 4-phenoxazinyl-1-phenyl, 4-phenothizainyl-1-phenyl, 4-(9,9-dimethyl)acridinyl-1-phenyl, 4-(9-methyl)-phenazinyl-1-phenyl, 4-(9-phenyl)phenazinyl-1-phenyl and 3,5-bis-carbazolyl-1-phenyl. The invention further relates to an organic electroluminescent device which comprises a light-emitting layer, and luminescent dye of the light-emitting layer is the thermal activation delayed fluorescent material. The singlet state-triplet state energy gap (delta EST) of the thermal activation delayed fluorescent material is very small, triplet state excitors can be converted into singlet state excitors through inverse intersystem crossing (RIST) to emit light, and the efficiency and stability of an OLED device can be improved. The formula is shown in the description.

The invention relates to redox-switchable material comprising a redox-active moiety adsorbed, bonded or both, to a semiconductor material. Among the preferred redox-active moieties disclosed herein are ferrocenes, acridines, and quinones though any such moiety may be employed. The redox-switchable material of this invention may be used to selectively remove one or more selected solutes from an aqueous solution wherein adsorption / complexation of the solute is influenced by the oxidation state of the redox-active moiety. In an alternative embodiment, inclusion moieties that are covalently bound to the redox-active moiety are employed to achieve selective complexation of the desired solute. Other possible applications of the disclosed materials are photoerasable writing media, electrochromic or photochromic materials, catalysis, and solar energy storage.

The invention relates to a kit for detecting neutrophil gelatinase-associated lipocalin content based on chemiluminescence immunoassay. According to the invention, by employing a double-antibody sandwich immunization analysis method, a chemiluminescence magnetic microspheres immunization technology is used, anti-NGAL antibody-coated magnetic microspheres for specifically combining with NGAL antigen of a standard substance / sample in a reaction cup, then are reacted to another strain anti-NGAL antibody labelled with acridine salt to form an immunization compound, through an acid-base chemical reaction of a pre-Trigger and a Trigger, relative light unit (RLU / s) of the chemiluminescence reaction can be measured; the NGAL antigen content in the sample is in direct proportion to the relative light unit (RLU / s) measured by an optical system, determination of NGAL content in an urine specimen can be determined through standard curve fitting; and the method has the obvious advantages of high sensitivity, strong specificity, good stability, simple operation and low cost.

The present invention relates to a liquid crystal aligning agent, polyorganosiloxane, a liquid crystal aligning film, a forming method thereof and a liquid crystal display element. The present invention provides the liquid crystal aligning agent which can form the liquid crystal aligning film that can generate a pretilt angle with long time stability through an optical aligning method. The liquid crystal aligning agent comprises radiation-sensitive linear polyorganosiloxane which is prepared through the reaction of the following components: specific polyorgansiloxane with epoxy radical; (A) cinnamic acid derivative; and (B) a specific compound with a radiation-sensitive structure that is preferably selected from: acetophenone structure, benzophenone structure, anthraquinone structure, biphenyl structure, carbazole structure, nitro-aryl structure, fluorenes structure, naphthalene structure, anthracene structure, acridine structure and indole structure.

Methods and devices are provided for reducing the concentration of low molecular weight compounds in a biological composition, while substantially maintaining a desired biological activity of the biological composition. The device comprises highly porous adsorbent particles, and the adsorbent particles are immobilized by an inert matrix. The matrix containing the particles is contained in a housing, and the particles range in diameter from about 1 μm to about 200 μm. The matrix can be fibrous, and the particles can have a surface area greater than 750 m2 / g and a pore diameter between about 25 and 800 Å. The device can be used to adsorb and remove a pathogen-inactivating compound that is a nucleic acid-binding compound such as psoralen, an acridine derivative or a dye from a biological composition such as a blood product.

The present invention relates to derivatives of 4-(Thio- or Selenoxanthene-9-ylidene)-piperidine or acridine and pharmaceutically acceptable salts thereof, use of these compounds as a medicament and for the manufacture of a medicament for treatment of a disease state which can be alleviated by treatment with a 5-HT2B antagonist.

The invention relates to a chemiluminescent immunoassay method, in particular to a method for analyzing an acridine ester labeled antigen or an acridine ester labeled antibody and an immunoassay kit prepared by same. An acridine ester label is provided with a special luminescent group in a chemical structure, and the special group directly participates in luminescent reaction in the analyzing process of luminescent immunization; the substance does not have background luminescence usually, can be used for detecting a sample with low concentration or trace concentration in the reaction and is a luminescent agent with high luminescent efficiency; and molecules of acridine ester I and acridine ester II and acridine amide III can be combined with an antibody (antigen) to generate the labeled antibody with high chemiluminescent activity and immunological reaction specificity.

The invention relates to redox-switchable material comprising a redox-active moiety adsorbed, bonded or both, to a semiconductor material. Among the preferred redox-active moieties disclosed herein are ferrocenes, acridines, and quinones though any such moiety may be employed. The redox-switchable material of this invention may be used to selectively remove one or more selected solutes from an aqueous solution wherein adsorption / complexation of the solute is influenced by the oxidation state of the redox-active moiety. In an alternative embodiment, inclusion moieties that are covalently bound to the redox-active moiety are employed to achieve selective complexation of the desired solute. Other possible applications of the disclosed materials are photoerasable writing media, electrochromic or photochromic materials, catalysis, and solar energy storage.

The invention relates to novel acridine derivatives of the formula 1, to their preparation and to their use as medicaments, in particular for the treatment of tumors.

The invention relates to a chemical illumination immunity analysis method for checking human cTnT, which uses acridiniumester and / or alkaline phosphatase as label. The immunity reaction uses two-site immunoassay and / or competition law. The immunity reaction can use streptavidin-biotin two-site immunoassay to improve sensitivity. The invention uses NaOH and H2O2 as acridiniumester illumination initiating agent, uses 1, 2-dioxo cyclohexane derivative (adamantine derivative) as the illumination substrate of alkaline phosphatase, and uses fluorescein derivative and surface activator as illumination renforcing agent. The solid carrier is orifice plate, macromolecule polymer tube (ball) and ferriferrous oxide magnetic particles or the like.

The invention relates to acridine derivatives of which the structure is disclosed as Formula (1). When the electronic transmission layer of the electroluminescent device is prepared from the material provided by the invention, the turn-on voltage of the device can be lowered, the luminescence efficiency of the device can be enhanced, and the service life of the device can be prolonged.

Acridine containing cisplatin compounds have been disclosed that show greater efficacy against cancer than other cisplatin compounds. Methods of delivery of those more effective cisplatin compounds to the nucleus in cancer cells is disclosed using one or more amino acids, one or more sugars, one or more polymeric ethers, C1-6alkylene-phenyl-NH—C(O)—R15, folic acid, αvβ3 integrin RGD binding peptide, tamoxifen, endoxifen, epidermal growth factor receptor, antibody conjugates, kinase inhibitors, diazoles, triazoles, oxazoles, erlotinib, and / or mixtures thereof; wherein R15 is a peptide.

The invention provides a preparation method of acridine compounds, and relates to the technical field of photoinitiator. The preparation method comprises the following steps of: taking substituted N-methyl anthranilic acid as initial raw material, generating substituted acridone under the condition of acid, carrying out reaction on substituted bromobenzene and magnesium to generate grignard reagent, carrying out reaction on substituted acridone and the grignard reagent to generate substituted 9-oxhydryl-9-phenylacridine, and reducing to obtain the substituted 9-phenylacridine compounds. Different from the conventional synthesis route, the preparation method of the acridine compounds provided by the invention has more operation steps compared with the conventional one-step method, thus being slightly lower in yield compared with the conventional synthesis route, however, the preparation condition is mild relatively, and the high-temperature and high-pressure reaction and the use of expensive heavy metal catalyst can be avoided, so that the preparation method is good in environment protection.

The invention relates to a 9-phenylacridine photoinitiator and a preparation method thereof, wherein 9-phenylacridine (compound 1) and some 9-(substituted phenyl) acridine compounds such as 9-(4-methyl phenyl) acridine (compound 2), 9-(3-methyl phenyl) acridine (compound 3), 9-(2-methyl phenyl) acridine (compound 4) and 9-(2-chlorophenyl) acridine (compound 5) can be used as a photoinitiator and is widely used for unsaturated resin and light-cured materials formed by monomers of the unsaturated resin. The preparation method takes diphenylamine as starting materials, and the diphenylamine is directly reacted with benzoic acid or substituted benzoic acid under the catalysis of a composite catalyst formed by zinc chloride and 85 percent phosphoric acid to produce the 9-phenylacridine (compound 1) and the 9-(substituted phenyl) acridine compounds 2 to 5, thereby the yield of the compounds 1 to 5 can reach above 70 percent, all the product purities are larger than 98 percent, and the technology can satisfy the requirements of industrial production.

The invention discloses a 9,9'-spiral acridine-containing compound. 9,9'-spiral acridine is taken as a core and the 9,9'-spiral acridine is combined with peripheral electrophilic Ar and Ar' units. The invention further discloses a preparation method of the 9,9'-spiral acridine-containing compound. The 9,9'-spiral acridine-containing compound is obtained through selecting different halogen-substituted Ar unit and Ar' unit, carrying out Buchwald-Hartwig coupled reaction on 10H, 10'H-9,9'-spiral acridine, carrying out copper-catalyzed aryl halide amination reaction or carrying out nucleophilic substitution reaction under a strong alkaline condition. The invention further discloses an application of the 9,9'-spiral acridine-containing compound. The 9,9'-spiral acridine-containing compound has high fluorescence and certain conductivity, and can be used for fabricating a light-emitting layer of an organic light-emitting diode as a luminous body.

The invention belongs to the field of organic photoelectric material technology, and discloses an organic small molecule luminescent material and an organic electroluminescent device prepared from same. The organic small molecule luminescent material uses 9,9-dimethyl-10- phenyl acridine or 10-phenyl phenoxazine as an electron providing unit, and is connected with a different electron withdrawing unit at 2-site of the acridine group or the 3-site of the phenoxazine group to obtain a series of novel efficient organic small molecule luminescent materials. The organic small molecule luminescent material can change the characteristic of intramolecular charge transfer in the material, can make the luminescence peak of the luminescent material has a blue-shift, can be used as a luminescent layer for the organic electroluminescent device, and has a high device efficiency.

Acridine containing cisplatin compounds have been disclosed that show greater efficacy against cancer than other cisplatin compounds. Methods of delivery of those more effective cisplatin compounds to the nucleus in cancer cells is disclosed using one or more amino acids, one or more sugars, one or more polymeric ethers, C1-6alkylene-phenyl-NH—C(O)—R15, folic acid, αvβ3 integrin RGD binding peptide, tamoxifen, endoxifen, epidermal growth factor receptor, antibody conjugates, kinase inhibitors, diazoles, triazoles, oxazoles, erlotinib, and / or mixtures thereof; wherein R15 is a peptide.

The invention provides a novel acridine compound and organic light-emitting devices thereof, belongs to the technical field of organic photoelectric materials, and aims to solve the technical problems of low light-emitting efficiency, high driving voltage, short service life and low light-emitting performance of the organic photoelectric material in the prior art. Compared with the prior art, the light-emitting performance of the organic light-emitting devices based on organic electroluminescence device compounds and ink compositions can be obviously improved; the novel acridine compound is used as an excellent OLED material.

The invention discloses an acridine derivative represented by the formula I and a preparation method and application thereof. The formula I represents a compound or a medically accepted salt, ester and solvent composition thereof; Z is NHCH2, NHCH2CH2, NHCH2CH2CH2 or OCH2; the compound represented by the formula I has a deoxyribonucleic acid (DNA) connection function and inhibition activity to topoisomerase; the compound or the medically accepted salt, ester and solvent composition thereof can be effectively used for preparing a DNA connector, a topoisomerase inhibitor and an eucaryon biological tumor cell multiplication inhibitor and tumor preventing and / or treating medicines.

Fluorescent biosensor molecules, fluorescent biosensors and systems, as well as methods of making and using these biosensor molecules and systems are described. These biosensor molecules address the problem of obtaining fluorescence emission at wavelengths greater than about 500 nm. Biosensor molecules generally include an (1) an acridine-based fluorophore, (2) a linker moiety and (3) a boronate substrate recognition / binding moiety, which binds polyhydroxylate analytes, such as glucose. These biosensor molecules further include a “switch” element that is drawn from the electronic interactions among these submolecular components. This fluorescent switch is generally “off” in the absence of bound polyhydroxylate analyte and is generally “on” in the presence of bound polyhydroxylate analyte. Thus, the reversible binding of a polyhydroxylate analyte essentially turns the fluorescent switch “on” and “off”. This property of the biosensor molecules, as well as their ability to emit fluorescent light at greater than about 500 nm, renders these biosensor molecules particularly well-suited for detecting and measuring in-vivo glucose concentrations.

The invention discloses an acridinium ester derivative, a synthesis method and application thereof. The chemiluminescent acridinium ester derivative provided by the invention has a structural formula shown as formula I. The invention further discloses a synthesis method for the compound shown as formula I, and the method includes: (1) synthesizing acridine-9-thiocarboxylic acid p-trifluoromethylbenzene ester; (2) synthesizing 10-methyl-acridine-9-thiocarboxylic acid p-trifluoromethylbenzene ester; (3) synthesizing 10-methyl-9, 10-dihydroacridine-9-thiocarboxylic acid p-trifluoromethylbenzene ester; and (4) synthesizing TfS-APS. The acridinium ester derivative provided by the invention can be used as an immunoassay tracer to a chemiluminescence immunoassay reagent system with alkaline phosphatase (ALP) as the marker enzyme. The application effect in a kit proves that the acridinium ester derivative involved in the invention can detect 1*10<-19>mol ALP molecules, and has the advantages of high sensitivity, long luminescence duration, simple use, constant intensity under room temperature condition, and no need for precise temperature control, etc.

A method for the detection or quantitation of an analyte in a biological sample is disclosed. The method comprises the steps of selecting a biological sample suspected of containing a target analyte and binding the target analyte in the sample to a binding partner conjugated to an acridinium compound, wherein the acridinium compound comprises an acridinium nucleus having an electron-donating substituent directly attached to the acridinium nucleus at the C2 position. Chemiluminescent acridinium compounds useful in the method have emission maxima close to or in the near infrared (NIR) region (>590 nm). These chemiluminescent acridinium compounds when used in conjunction with short wavelength-emitting acridinium esters (with emission maxima below 450 nm) can be highly useful labels for the simultaneous detection of multiple target analytes in a single assay.

The present invention relates to a negative photosensitive resin composition which is sensitive to long wavelength ultraviolet rays, and more specifically, to a negative photosensitive resin composition comprising: a) one or a mixture of copolymers selected from i) an acrylic copolymer, ii) a polyimide-based copolymer, and iii) a siloxane-based copolymer; b) a photoinitiator; and c) an acridine-based photosensitizer having a specific structure. According to the present invention, the negative photosensitive resin composition has excellent resolution, transmittance, thermochromism resistance, adhesive force and the like, particularly, has excellent sensitivity at long wavelength ultraviolet rays of 405-435 nm, and thus is appropriate for use in an exposure device for the exclusive use of GH-line or a next generation digital exposure device.

This invention provides an electrode electrolyte for a solid polymer-type fuel cell, in which a cost problem and a problem related to recovery of catalyst metals are solved, having excellent proton conductivity, dimensional stability and heat resistance.An electrode electrolyte for a solid polymer electrolyte-type fuel cell contains a polymer, which has a polyphenylene structure as a main chain and both a sulfonic acid group and a nitrogen-containing heterocyclic group as a side chain. A side chain having the nitrogen-containing heterocyclic group has a structure represented by the following general formula (D).(In formula, Z represents at least one kind of structures selected from a group consisting of a direct bond, —O— and —S—, Y represents at least one kind of structures selected from a group consisting of —CO—, —SO2—, —SO—, —CONH—, —COO—, —(CF2)1— (1 is an integer of 1 to 10) and —C(CF3)2— and R20 represents a nitrogen-containing heterocyclic group. q represents an integer of 1 to 5 and p represents an integer of 0 to 4.)The above nitrogen-containing heterocyclic group is at least one kind of group derived from a compound selected from the group consisting of nitrogen-containing heterocyclic compounds including pyrrole, thiazole, isothiazole, oxazole, isoxazole, pyridine, imidazole, imidazoline, pyrazole, 1,3,5-triazine, pyrimidine, pyridazine, pyrazine, indole, quinoline, isoquinoline, purine, benzimidazole, benzoxazole, benzothiazole, tetrazole, tetrazine, triazole, carbazole, acridine, quinoxaline and quinazoline and derivatives thereof.

The present invention pertains to acridone and acridine compounds of formula (I), wherein either: (a) K is ═O, L is —H, alpha single bond, beta is a double bond, gamma is a single bond (acridones); or, (b) K is a 9-substituent, L is absent, alpha is a double bond, beta is a single bond, gamma is a double bond (acridines); and wherein: J1 is a 2- or 3-substituent; J2 is a 6- or 7-substituent; J1 and J2 are each independently a group of the formula —NHCO(CH2)nNR1R2, wherein: n is an integer from 1 to 5; and, R1 and R2 are independently hydrogen, C1-7alkyl, C3-20heterocyclyl, or C5-20aryl, or R1 and R2, taken together with the nitrogen atom to which they are attached, form a heterocyclic ring having from 3 to 8 ring atoms; and wherein, when K is a 9-substituent, K is a group of the formula —N(RN)Q, wherein: RN is an amino substituent and is hydrogen, C1-7alkyl, C3-20heterocyclyl, or C5-20aryl; and, Q is C1-7alkyl, C3-20heterocyclyl, or C5-20aryl, and is optionally substituted; and pharmaceutically acceptable salts, esters, amides, solvates, hydrates, and protected forms thereof. The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit telomerase, to regulate cell proliferation, and in the treatment of proliferative conditions, such as cancer.

The invention discloses an orange red light thermal activated delay fluorescent material which is 3,6,11-tri(9,9-dimethyl acridine-10(9H)-yl)-dibenzo[a,c] phenazine (3DMAC-BP). The fluorescent material has a rigid large-plane twisted structure and a remarkable internal charge transfer (ICT) effect, has an organic red thermal activated delay fluorescence property (TADF), a high fluorescence quantumyield (PLQY) and excellent thermal stability, and is simple in synthesis preparation steps, and raw materials are easy to obtain, synthesis and purification processes are simple, the yield is high and large-scale synthesis and preparation can be achieved. The organic electroluminescence device based on the material is capable of emitting orange red fluorescence (lambda=606nm), the external quantum efficiency EQE of the device is as high as 22%, and the device has the advantages of being low in driving voltage, good in light emission stability, and the like, and has good application prospectsin fields such as lighting, panel display, sensation, night vision, bioimaging and the like.